Chen Y, Jin Y, Li K, Qiu H, Jiang Z, Zhu J
J Parkinsons Dis. 2023; 13(7):1107-1125.
PMID: 37899063
PMC: 10657691.
DOI: 10.3233/JPD-230059.
van der Putten G, de Baat C
J Clin Med. 2023; 12(13).
PMID: 37445340
PMC: 10342842.
DOI: 10.3390/jcm12134306.
Verhoeff M, Koutris M, Tambach S, Eikenboom D, de Vries R, Berendse H
Eur J Pain. 2022; 26(10):2036-2059.
PMID: 36063442
PMC: 9826258.
DOI: 10.1002/ejp.2031.
Garcia-De-La-Fuente A, Lafuente-Ibanez-de-Mendoza I, Lartitegui-Sebastian M, Marichalar-Mendia X, Echebarria-Goikouria M, Aguirre-Urizar J
Med Oral Patol Oral Cir Bucal. 2022; 27(5):e419-e425.
PMID: 35368008
PMC: 9445606.
DOI: 10.4317/medoral.25348.
John T, Vasanthy B, Madhavanpillai B, Gomez M, Kuriakose R
J Indian Soc Periodontol. 2021; 25(6):538-543.
PMID: 34898921
PMC: 8603805.
DOI: 10.4103/jisp.jisp_749_20.
Oral Health Disorders in Parkinson's Disease: More than Meets the Eye.
Auffret M, Meuric V, Boyer E, Bonnaure-Mallet M, Verin M
J Parkinsons Dis. 2021; 11(4):1507-1535.
PMID: 34250950
PMC: 8609694.
DOI: 10.3233/JPD-212605.
Oral health and implant therapy in Parkinson's patients: review.
Bollero P, Franco R, Cecchetti F, Miranda M, Barlattani Jr A, Dolci A
Oral Implantol (Rome). 2018; 10(2):105-111.
PMID: 29876035
PMC: 5965075.
DOI: 10.11138/orl/2017.10.2.105.
Oral health, temporomandibular disorder, and masticatory performance in patients with Charcot-Marie-Tooth type 2.
Rezende R, Bonjardim L, Neves E, Santos L, Nunes P, Garcez C
ScientificWorldJournal. 2014; 2013:425651.
PMID: 24391462
PMC: 3874298.
DOI: 10.1155/2013/425651.
Oral rehabilitation of a Parkinson's patient: A case report.
Singh Y, Saini M, Garg N
World J Clin Cases. 2013; 1(1):67-70.
PMID: 24303468
PMC: 3845922.
DOI: 10.12998/wjcc.v1.i1.67.
Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease.
Cicciu M, Risitano G, Lo Giudice G, Bramanti E
Parkinsons Dis. 2013; 2012:541908.
PMID: 23320249
PMC: 3539438.
DOI: 10.1155/2012/541908.
Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.
Beach T, Adler C, Sue L, Vedders L, Lue L, White Iii C
Acta Neuropathol. 2010; 119(6):689-702.
PMID: 20306269
PMC: 2866090.
DOI: 10.1007/s00401-010-0664-3.
Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.
Merello M
Drugs Aging. 2008; 25(12):1007-19.
PMID: 19021300
DOI: 10.2165/0002512-200825120-00003.
Evidence for the effectiveness of botulinum toxin for sialorrhoea.
Truong D, Bhidayasiri R
J Neural Transm (Vienna). 2008; 115(4):631-5.
PMID: 18250951
DOI: 10.1007/s00702-007-0861-y.
Significantly reduced salivary nitric oxide synthesis in patients with Parkinson's disease.
Huskic J, Paperniku A, Husic A, Alendar F, Mulabegovic N
Bosn J Basic Med Sci. 2005; 5(3):86-9.
PMID: 16351589
PMC: 7202145.
DOI: 10.17305/bjbms.2005.3277.
Taste responses in patients with Parkinson's disease.
Sienkiewicz-Jarosz H, Scinska A, Kuran W, Ryglewicz D, Rogowski A, Wrobel E
J Neurol Neurosurg Psychiatry. 2004; 76(1):40-6.
PMID: 15607993
PMC: 1739334.
DOI: 10.1136/jnnp.2003.033373.
Oral health conditions in patients with Parkinson's disease.
Nakayama Y, Washio M, Mori M
J Epidemiol. 2004; 14(5):143-50.
PMID: 15478669
PMC: 8787205.
DOI: 10.2188/jea.14.143.